Kimberly-Clark has appointed Joseph Romanelli, president of Human Health International at Merck, to its board of directors, increasing the board size to 13.
Romanelli brings global leadership experience and expertise in science and healthcare.
He has led MSD’s international markets since 2022 and previously served as CEO of JiXing Pharmaceuticals.